Argon and diode laser photocoagulation in proliferative diabetic retinopathy

A preliminary report

R. Brancato, F. Bandello, G. Trabucchi, G. Leoni, R. Lattanzio

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Twenty-six eyes of 24 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with diode (810 nm) (13 eyes) and argon-green (514 nm) lasers (13 eyes). In the diode laser group, partial or total regression of neovascularizations was observed in 9 eyes (69.2%) while 4 (30.8%) remained unchanged. In argon-green group seven eyes (53.8%) showed partial or total regression, 5 (38.2%) unchanged and 1 (7.6%) worsened. The mean follow-up time was 6.8 months (SD 2.2) for the diode laser group and 7.8 months (SD 3.2) for the argon-green laser group. The authors discuss the results and the clinical side-effects observed on the basis to the further development of the diode laser in clinical practice.

Original languageEnglish
Pages (from-to)233-237
Number of pages5
JournalLasers and Light in Ophthalmology
Volume3
Issue number3
Publication statusPublished - 1990

Fingerprint

Semiconductor Lasers
Light Coagulation
Argon
Diabetic Retinopathy
Lasers

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Argon and diode laser photocoagulation in proliferative diabetic retinopathy : A preliminary report. / Brancato, R.; Bandello, F.; Trabucchi, G.; Leoni, G.; Lattanzio, R.

In: Lasers and Light in Ophthalmology, Vol. 3, No. 3, 1990, p. 233-237.

Research output: Contribution to journalArticle

Brancato, R. ; Bandello, F. ; Trabucchi, G. ; Leoni, G. ; Lattanzio, R. / Argon and diode laser photocoagulation in proliferative diabetic retinopathy : A preliminary report. In: Lasers and Light in Ophthalmology. 1990 ; Vol. 3, No. 3. pp. 233-237.
@article{0e1e9347dd294b34b4a0886efab0e116,
title = "Argon and diode laser photocoagulation in proliferative diabetic retinopathy: A preliminary report",
abstract = "Twenty-six eyes of 24 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with diode (810 nm) (13 eyes) and argon-green (514 nm) lasers (13 eyes). In the diode laser group, partial or total regression of neovascularizations was observed in 9 eyes (69.2{\%}) while 4 (30.8{\%}) remained unchanged. In argon-green group seven eyes (53.8{\%}) showed partial or total regression, 5 (38.2{\%}) unchanged and 1 (7.6{\%}) worsened. The mean follow-up time was 6.8 months (SD 2.2) for the diode laser group and 7.8 months (SD 3.2) for the argon-green laser group. The authors discuss the results and the clinical side-effects observed on the basis to the further development of the diode laser in clinical practice.",
author = "R. Brancato and F. Bandello and G. Trabucchi and G. Leoni and R. Lattanzio",
year = "1990",
language = "English",
volume = "3",
pages = "233--237",
journal = "Lasers and Light in Ophthalmology",
issn = "0922-5307",
publisher = "Mosby",
number = "3",

}

TY - JOUR

T1 - Argon and diode laser photocoagulation in proliferative diabetic retinopathy

T2 - A preliminary report

AU - Brancato, R.

AU - Bandello, F.

AU - Trabucchi, G.

AU - Leoni, G.

AU - Lattanzio, R.

PY - 1990

Y1 - 1990

N2 - Twenty-six eyes of 24 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with diode (810 nm) (13 eyes) and argon-green (514 nm) lasers (13 eyes). In the diode laser group, partial or total regression of neovascularizations was observed in 9 eyes (69.2%) while 4 (30.8%) remained unchanged. In argon-green group seven eyes (53.8%) showed partial or total regression, 5 (38.2%) unchanged and 1 (7.6%) worsened. The mean follow-up time was 6.8 months (SD 2.2) for the diode laser group and 7.8 months (SD 3.2) for the argon-green laser group. The authors discuss the results and the clinical side-effects observed on the basis to the further development of the diode laser in clinical practice.

AB - Twenty-six eyes of 24 diabetic patients affected by proliferative diabetic retinopathy were randomly treated with diode (810 nm) (13 eyes) and argon-green (514 nm) lasers (13 eyes). In the diode laser group, partial or total regression of neovascularizations was observed in 9 eyes (69.2%) while 4 (30.8%) remained unchanged. In argon-green group seven eyes (53.8%) showed partial or total regression, 5 (38.2%) unchanged and 1 (7.6%) worsened. The mean follow-up time was 6.8 months (SD 2.2) for the diode laser group and 7.8 months (SD 3.2) for the argon-green laser group. The authors discuss the results and the clinical side-effects observed on the basis to the further development of the diode laser in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=0025053343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025053343&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 233

EP - 237

JO - Lasers and Light in Ophthalmology

JF - Lasers and Light in Ophthalmology

SN - 0922-5307

IS - 3

ER -